Clinical Cancer Research Grants AACR Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Clinical Cancer Research 14, 6683, October 15, 2008. doi: 10.1158/1078-0432.CCR-07-4389
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Isomura, M.
Right arrow Articles by Hiraoka, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Isomura, M.
Right arrow Articles by Hiraoka, M.

Cancer Therapy: Clinical

IL12RB2 and ABCA1 Genes Are Associated with Susceptibility to Radiation Dermatitis

Minoru Isomura1,6, Natsuo Oya7,8, Seiji Tachiiri8, Yuko Kaneyasu9, Yasumasa Nishimura10, Tetsuo Akimoto2,11, Masato Hareyama12, Tadasi Sugita13, Norio Mitsuhashi2, Takashi Yamashita3, Masahiko Aoki15, Heitetsu Sai8,14, Yutaka Hirokawa4,9, Koh-ichi Sakata12, Kumiko Karasawa4, Akihiro Tomida5, Takashi Tsuruo5, Yoshio Miki1,6, Tetsuo Noda1 and Masahiro Hiraoka8

Authors' Affiliations: 1 Genome Center, Japanese Foundation for Cancer Research; 2 Department of Radiology, Tokyo Women's Medical University, School of Medicine; 3 Department of Radiation Oncology, Cancer Institute Hospital; 4 Department of Radiology, School of Medicine, Juntendo University; 5 Institute of Molecular and Cellular Biosciences, The University of Tokyo; 6 Department of Molecular Genetics, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan; 7 Department of Radiation Oncology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; 8 Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan; 9 Department of Radiology, Hiroshima University, Hiroshima, Japan; 10 Department of Radiation Oncology, Kinki University School of Medicine, Osaka, Japan; 11 Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Japan; 12 Department of Radiology, Sapporo Medical University, School of Medicine, Sapporo, Japan; 13 Department of Radiology, Niigata Cancer Center Hospital; 14 Department of Radiology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan; and 15 Department of Radiology, Hirosaki University School of Medicine, Hirosaki, Japan

Requests for reprints: Yoshio Miki, Genome Center, Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, Tokyo 135-8550, Japan. Phone: 81-3-3570-0453; Fax: 81-3-3570-0454; E-mail: miki{at}jfcr.or.jp.

Purpose: Severe acute radiation dermatitis is observed in approximately 5% to 10% of patients who receive whole-breast radiotherapy. Several factors, including treatment-related and patient-oriented factors, are involved in susceptibility to severe dermatitis. Genetic factors are also thought to be related to a patient's susceptibility to severe dermatitis. To elucidate genetic polymorphisms associated with a susceptibility to radiation-induced dermatitis, a large-scale single-nucleotide polymorphism (SNP) analysis using DNA samples from 156 patients with breast cancer was conducted.

Experimental Design: Patients were selected from more than 3,000 female patients with early breast cancer who received radiotherapy after undergoing breast-conserving surgery. The dermatitis group was defined as patients who developed dermatitis at a National Cancer Institute Common Toxicity Criteria grade of ≥2. For the SNP analysis, DNA samples from each patient were subjected to the genotyping of 3,144 SNPs covering 494 genes.

Results: SNPs that mapped to two genes, ABCA1 and IL12RB2, were associated with radiation-induced dermatitis. In the ABCA1 gene, one of these SNPs was a nonsynonymous coding SNP causing R219K (P = 0.0065). As for the IL12RB2 gene, the strongest association was observed at SNP-K (rs3790568; P = 0.0013). Using polymorphisms of both genes, the probability of severe dermatitis was estimated for each combination of genotypes. These analyses showed that individuals carrying a combination of genotypes accounting for 14.7% of the Japanese population have the highest probability of developing radiation-induced dermatitis.

Conclusion: Our results shed light on the mechanisms responsible for radiation-induced dermatitis. These results may also contribute to the individualization of radiotherapy.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.